These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 7193025)

  • 1. Characterization of a new potent heparin. 4th communication: The effect of a new potent heparin preparation on lipid components and leucocytes in rats after subcutaneous application.
    Bhargava AS; Staben P; Schöbel C; Günzel P
    Arzneimittelforschung; 1980; 30(9):1562-6. PubMed ID: 7193025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of a new potent heparin. 7th communication: A comparative study of a new potent heparin in human after i.v. application.
    Bhargava AS; Wendt H; Günzel P
    Arzneimittelforschung; 1981; 31(2):386-8. PubMed ID: 7194658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of a new potent heparin. 1 communication: Determinations of anticoagulant activity of a high potency heparin preparation in vivo using dog as an experimental animal and in vitro using dog and human plasma.
    Bhargava AS; Heinick J; Schöbel C; Günzel P
    Arzneimittelforschung; 1980; 30(6):993-6. PubMed ID: 7191280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of a new potent heparin. 6th communication: The comparison of the anticoagulant effect of the sodium and calcium salts of a new potent heparin after s.c. injection in beagle dogs.
    Bhargava AS; Schöbel C; Günzel P
    Arzneimittelforschung; 1981; 31(1):79-82. PubMed ID: 7194097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postheparin serum lipolytic activity in psoriatic males.
    Pietrzak A; Lecewicz-Toruń B; Borzecki A
    Med Sci Monit; 2000; 6(4):729-34. PubMed ID: 11208400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of a new potent heparin. 3rd Communication: Determinations of anticoagulant activity of a new potent heparin preparation by thrombelastography in vitro using citrated dog and human blood.
    Bhargava AS; Freihube G; Günzel P
    Arzneimittelforschung; 1980; 30(8):1256-8. PubMed ID: 7192139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Metabolic effects and myocardial activity of heparin. Experimental research].
    Rognoni F; Piacenza G
    Boll Soc Ital Cardiol; 1975; 20(12):1693-8. PubMed ID: 1234467
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of low molecular weight heparins and unfractionated heparin after successive subcutaneous administration. A randomized controlled study in healthy volunteers.
    Pindur G; Heiden M; Köhler M
    Arzneimittelforschung; 1993 May; 43(5):542-7. PubMed ID: 8392345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of the effect of subcutaneous heparin on blood coagulability and blood lipids in diabetic patients].
    Ghanem MH; Tawfik S; Guirgis FK; el-Sawy M
    Therapeutique; 1971 May; 47(5):473-6. PubMed ID: 5562482
    [No Abstract]   [Full Text] [Related]  

  • 10. Anticoagulative effects of the inhaled low molecular weight heparin certoparin in healthy subjects.
    Scheuch G; Brand P; Meyer T; Herpich C; Müllinger B; Brom J; Weidinger G; Kohlhäufl M; Häussinger K; Spannagl M; Schramm W; Siekmeier R
    J Physiol Pharmacol; 2007 Nov; 58 Suppl 5(Pt 2):603-14. PubMed ID: 18204174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute effect of heparin on lipid parameters in patients on renal replacement therapy.
    Katopodis KP; Koliousi E; Gouva C; Balafa O; Bairaktari E; Ikonomou M; Elisaf MS; Siamopoulos KC
    ASAIO J; 2007; 53(1):46-9. PubMed ID: 17237649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of acetylsalicylic acid on plasma lipids and on post-heparin lipase activities.
    Sommariva D; Bonfiglioli D; Zanaboni L; Fasoli A
    Int J Clin Pharmacol Ther Toxicol; 1981 Mar; 19(3):112-6. PubMed ID: 7228453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effect of n-3 polyunsaturated fatty acids concentrate on isoproterenol-induced myocardial infarction in rats.
    Anandan R; Mathew S; Sankar TV; Viswanathan Nair PG
    Prostaglandins Leukot Essent Fatty Acids; 2007 Mar; 76(3):153-8. PubMed ID: 17275273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low molecular weight heparin does not necessarily reduce lipids and lipoproteins in hemodialysis patients.
    Kronenberg F; König P; Lhotta K; Steinmetz A; Dieplinger H
    Clin Nephrol; 1995 Jun; 43(6):399-404. PubMed ID: 7554525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in lipoprotein lipase activity and plasma liver lipids in thiram intoxicated rats.
    Sadurska B; Boguszewski B
    Acta Biochim Pol; 1993; 40(4):563-7. PubMed ID: 8140833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endurance swimming activates trout lipoprotein lipase: plasma lipids as a fuel for muscle.
    Magnoni L; Weber JM
    J Exp Biol; 2007 Nov; 210(Pt 22):4016-23. PubMed ID: 17981869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of a high single subcutaneous dose of unfractionated heparin on platelet function in dogs].
    Mischke R; Nimmerfall K
    Berl Munch Tierarztl Wochenschr; 2000 Feb; 113(2):60-4. PubMed ID: 10726363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on the metabolism and disposition of the new retinoid 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)carbamoyl] benzoic acid. 4th communication: absorption, metabolism, excretion and plasma protein binding in various animals and man.
    Mizojiri K; Okabe H; Sugeno K; Misaki A; Ito M; Kominami G; Esumi Y; Takaichi M; Harada T; Seki H; Inaba A
    Arzneimittelforschung; 1997 Mar; 47(3):259-69. PubMed ID: 9105544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dalteparin, a low molecular weight heparin, attenuates inflammatory responses and reduces ischemia-reperfusion-induced liver injury in rats.
    Harada N; Okajima K; Uchiba M
    Crit Care Med; 2006 Jul; 34(7):1883-91. PubMed ID: 16641616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Should blood samples be drawn on heparin-anticoagulant for lipid analysis?].
    Sassolas A; Cheillan D; Drai J; Bondon PJ; Cartier R
    Ann Biol Clin (Paris); 2004; 62(5):583-6. PubMed ID: 15355810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.